- -- 05 June 2010
- immatics announces Phase II Results with its Therapeutic Cancer Vaccine IMA901 in Patients with Advanced Renal Cell Carcinoma at ASCO
- -- 05 June 2010
- IMA901 data poster presented at ASCO Annual Meeting available for download now!
- -- 02 June 2010
- immatics enters Collaboration with the National Cancer Institute (NCI) to Advance the Development of IMA950 for Glioblastoma
- -- 17 May 2010
- IMA901 Phase II data presented at ASCO Annual Meeting in Chicago (June, 4-8)
- -- 17 May 2010
- Progress in preclinical projects presented at CIMT Annual Meeting (May, 26-28)
- -- 21 April 2010
- AACR Annual Meeting 2010 posters now available for download
- -- 16 February 2010
- immatics Enters Collaboration with Cancer Research UK to Develop Multi-target Rationally Designed Therapeutic Cancer Vaccine
AACR Annual Meeting 2010 posters now available for download
Tuebingen, April 2010 – Unfortunately, due to flight cancellations caused by the volcanic eruption in Iceland, immatics team members were not able to visit the AACR. However, if you are interested in the projects which were to be presented you can download the posters here!
- Project 1: IMA950 - A novel multi-peptide cancer vaccine for treatment of glioma
- Project 2: Quantitative HLA-peptidomics by XPRESIDENT - differential quantitation of naturally processed HLA-restricted peptides for cancer immunotherapy development
- Project 3: Synergy of the immunomodulators GM-CSF and imiquimod for peptide-based therapeutic